CytomX Therapeutics, Inc. short interest in 2021
In 2021, CytomX Therapeutics, Inc.'s disclosed short interest ran from 6.52% of shares outstanding on 15 Jan 2021 to 4.74% on 31 Dec 2021, a change of -1.78 percentage points. The year's high was 10.74% on 30 Jul 2021 and its low 4.74% on 31 Dec 2021, averaging 8.13% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.67 days on 15 Oct 2021. Full history: CytomX Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 6.52% (15 Jan 2021)
- End of year
- 4.74% (31 Dec 2021)
- Change
- -1.78 pp
- High
- 10.74% (30 Jul 2021)
- Low
- 4.74% (31 Dec 2021)
- Average
- 8.13%
- Highest days to cover
- 14.67 (15 Oct 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 6.52% | 8.17 | |
| 29 Jan 2021 | 7.87% | 1.84 | results (8-K) |
| 12 Feb 2021 | 5.13% | 3.59 | |
| 26 Feb 2021 | 5.13% | 5.30 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 6.05% | 6.23 | |
| 31 Mar 2021 | 9.90% | 6.22 | |
| 15 Apr 2021 | 9.55% | 7.23 | |
| 30 Apr 2021 | 10.25% | 8.49 | |
| 14 May 2021 | 10.35% | 5.22 | 10-Q filed, results (8-K) |
| 28 May 2021 | 10.21% | 12.59 | |
| 15 Jun 2021 | 10.27% | 9.67 | |
| 30 Jun 2021 | 10.21% | 6.48 | |
| 15 Jul 2021 | 10.23% | 9.21 | |
| 30 Jul 2021 | 10.74% | 13.29 | |
| 13 Aug 2021 | 10.25% | 8.25 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 9.05% | 9.34 | |
| 15 Sep 2021 | 8.04% | 9.66 | |
| 30 Sep 2021 | 7.46% | 7.53 | |
| 15 Oct 2021 | 6.91% | 14.67 | |
| 29 Oct 2021 | 7.43% | 8.85 | |
| 15 Nov 2021 | 7.17% | 5.28 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 5.61% | 3.46 | |
| 15 Dec 2021 | 6.12% | 3.72 | |
| 31 Dec 2021 | 4.74% | 1.03 |
See also: CytomX Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.